Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse.

MLA

Cailleux, Frédéric, et al. “Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse.” JCO Precision Oncology, vol. 6, Sept. 2022, p. e2200148. EBSCOhost, https://doi.org/10.1200/PO.22.00148.

APA

Cailleux, F., Agostinetto, E., Lambertini, M., Rothé, F., Wu, H.-T., Balcioglu, M., Kalashnikova, E., Vincent, D., Viglietti, G., Gombos, A., Papagiannis, A., Veys, I., Awada, A., Sethi, H., Aleshin, A., Larsimont, D., Sotiriou, C., Venet, D., & Ignatiadis, M. (2022). Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse. JCO Precision Oncology, 6, e2200148. https://doi.org/10.1200/PO.22.00148

Chicago

Cailleux, Frédéric, Elisa Agostinetto, Matteo Lambertini, Françoise Rothé, Hsin-Ta Wu, Mustafa Balcioglu, Ekaterina Kalashnikova, et al. 2022. “Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse.” JCO Precision Oncology 6 (September): e2200148. doi:10.1200/PO.22.00148.